Review of Select Practice Parameters, Evidence-Based Treatment Algorithms, and International Guidelines for Hereditary Angioedema

Clinical Reviews in Allergy and Immunology

Volumn 51, Issue 2, 2016, Pages 193-206

  Jose, Jaison ^a   Zacharias, Jamie ^a   Craig, Timothy ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Androgens; Angioedema; C1 esterase inhibitor; Children; Guidelines; HAE prophylaxis; Hereditary angioedema (HAE); Practice parameter; Pregnancy; Type 2 HAE; Type I HAE

Indexed keywords

AMINOCAPROIC ACID; ANDROGEN; BRADYKININ B2 RECEPTOR ANTAGONIST; COMPLEMENT COMPONENT C1S INHIBITOR; DANAZOL; ECALLANTIDE; FRESH FROZEN PLASMA; ICATIBANT; KALLIKREIN INHIBITOR; METHYLTESTOSTERONE; OXANDROLONE; STANOZOLOL; TRANEXAMIC ACID;

ALGORITHM; ANGIONEUROTIC EDEMA; CANADA; DISEASE SEVERITY; DRUG EFFECT; EVIDENCE BASED PRACTICE; FOLLOW UP; HUMAN; HUNGARY; IMMUNOPROPHYLAXIS; LABORATORY TEST; LONG TERM CARE; MORBIDITY; MORTALITY; OBSTETRICS; PATIENT CARE; PRACTICE GUIDELINE; REVIEW; SHORT COURSE THERAPY; TREATMENT PLANNING; ANGIOEDEMAS, HEREDITARY; DIAGNOSTIC PROCEDURE; DISEASE MANAGEMENT; PREMEDICATION; RISK FACTOR;

ALGORITHMS; ANGIOEDEMAS, HEREDITARY; DIAGNOSTIC TECHNIQUES AND PROCEDURES; DISEASE MANAGEMENT; HUMANS; PRACTICE GUIDELINES AS TOPIC; PREMEDICATION; RISK FACTORS;

EID: 84964570170     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-016-8546-7     Document Type: Review

References (28)

1. Gompels MM, Lock RJ, Morgan JE et al (2002) A multicentre evaluation of the diagnostic efficiency of serological investigations for C1 inhibitor deficiency. J Clin Pathol 55:145–147
2. Bowen T, Hebert J, Ritchie B et al (2003) Management of hereditary angioedema: a Canadian approach. Transfus Apher Sci Off J World Apher Assoc Off J Eur Soc Haemapheresis 29:205–214. doi:10.1016/j.transci.2003.08.009
3. Agostoni A, Aygören-Pürsün E, Binkley KE et al (2004) Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 114:S51–131. doi:10.1016/j.jaci.2004.06.047
4. Bowen T, Cicardi M, Farkas H et al (2004) Canadian 2003 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. J Allergy Clin Immunol 114:629–637. doi:10.1016/j.jaci.2004.06.043
5. Gompels MM, Lock RJ, Abinun M et al (2005) C1 inhibitor deficiency: consensus document. Clin Exp Immunol 139:379–394. doi:10.1111/j.1365-2249.2005.02726.x
6. Bowen T, Cicardi M, Bork K et al (2008) Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol 100:S30–40
7. Reshef A, Kivity S, Toubi E (2009) Clinical guidelines for the diagnosis and management of hereditary angioedema. Harefuah update. Allergy & Immunology 12–20 [Heb].
8. Bowen T, Cicardi M, Farkas H et al (2010) 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol Off J Can Soc Allergy Clin Immunol 6:24. doi:10.1186/1710-1492-6-24
9. Longhurst HJ, Farkas H, Craig T et al (2010) HAE international home therapy consensus document. Allergy Asthma Clin Immunol Off J Can Soc Allergy Clin Immunol 6:22. doi:10.1186/1710-1492-6-22
10. Caballero T, Baeza ML, Cabañas R et al (2011) Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part II. Treatment, follow-up, and special situations. J Investig Allergol Clin Immunol 21:422–441, quiz 442–443
11. Caballero T, Baeza ML, Cabañas R et al (2011) Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosis. J Investig Allergol Clin Immunol 21:333–347, quiz follow 347
12. Bork K, Maurer M, Bas M, et al. (2011) German Guidelines for hereditary angioedema due to C1-INH deficiency. Available from: www.angioedema.de/englisch/infos.htm. Accessed 25 Dec 2015
13. Cicardi M, Bork K, Caballero T et al (2012) Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group. Allergy 67:147–157. doi:10.1111/j.1398-9995.2011.02751.x
14. Craig T, Aygören-Pürsün E, Bork K et al (2012) WAO guideline for the management of hereditary angioedema. World Allergy Organ J 5:182–199. doi:10.1097/WOX.0b013e318279affa
15. Caballero T, Farkas H, Bouillet L et al (2012) International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency. J Allergy Clin Immunol 129:308–320. doi:10.1016/j.jaci.2011.11.025
16. Wahn V, Aberer W, Eberl W et al (2012) Hereditary angioedema (HAE) in children and adolescents-a consensus on therapeutic strategies. Eur J Pediatr 171:1339–1348. doi:10.1007/s00431-012-1726-4
17. Zuraw BL, Bork K, Binkley KE et al (2012) Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel. Allergy Asthma Proc Off J Reg State Allergy Soc 33(Suppl 1):S145–156. doi:10.2500/aap.2012.33.3627
18. Zuraw BL, Banerji A, Bernstein JA et al (2013) US Hereditary Angioedema Association Medical Advisory Board 2013 recommendations for the management of hereditary angioedema due to C1 inhibitor deficiency. J Allergy Clin Immunol Pract 1:458–467. doi:10.1016/j.jaip.2013.07.002
19. Jaiganesh T, Wiese M, Hollingsworth J et al (2013) Acute angioedema: recognition and management in the emergency department. Eur J Emerg Med Off J Eur Soc Emerg Med 20:10–17. doi:10.1097/MEJ.0b013e328356f76e
20. Cicardi M, Aberer W, Banerji A et al (2014) Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy 69:602–616. doi:10.1111/all.12380
21. Betschel S, Badiou J, Binkley K et al (2014) Canadian hereditary angioedema guideline. Allergy Asthma Clin Immunol Off J Can Soc Allergy Clin Immunol 10:50. doi:10.1186/1710-1492-10-50
22. Moellman JJ, Bernstein JA, Lindsell C et al (2014) A consensus parameter for the evaluation and management of angioedema in the emergency department. Acad Emerg Med Off J Soc Acad Emerg Med 21:469–484. doi:10.1111/acem.12341
23. Cicardi M, Bellis P, Bertazzoni G et al (2014) Guidance for diagnosis and treatment of acute angioedema in the emergency department: consensus statement by a panel of Italian experts. Intern Emerg Med 9:85–92. doi:10.1007/s11739-013-0993-z
24. Longhurst HJ, Tarzi MD, Ashworth F et al (2015) C1 inhibitor deficiency: 2014 United Kingdom consensus document. Clin Exp Immunol 180:475–483. doi:10.1111/cei.12584
25. Giavina-Bianchi P, França AT, Grumach AS et al (2011) Brazilian guidelines for the diagnosis and treatment of hereditary angioedema. Clin São Paulo Braz 66:1627–1636
26. Horiuchi T, Ohi H, Ohsawa I et al (2012) Guideline for hereditary angioedema (HAE) 2010 by the Japanese Association for Complement Research—secondary publication. Allergol Int Off J Jpn Soc Allergol 61:559–562. doi:10.2332/allergolint.12-RAI-0471
27. Prematta MJ, Prematta T, Craig TJ (2008) Treatment of hereditary angioedema with plasma-derived C1 inhibitor. Ther Clin Risk Manag 4:975–982
28. Kuhlen JL, Banerji A (2015) Hereditary angioedema: special consideration in children, women of childbearing age, and the elderly. Allergy Asthma Proc Off J Reg State Allergy Soc 36:425–432. doi:10.2500/aap.2015.36.3911